You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 4, April 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentaries
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

In Pursuit of the Molecular Neuropathology of Schizophrenia

John Q. Trojanowski, MD, PhD; Steven E. Arnold, MD
Departments of Pathology and Laboratory Medicine and Psychiatry University of Pennsylvania School of Medicine HUP/Maloney, Room A009 36th and Spruce streets Philadelphia, PA 19104-4283

Arch Gen Psychiatry. 1995;52(4):274-276.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The search for the defining neuropathological features of schizophrenia continues to be one of the highest priority areas of research on this severely debilitating and very common neuropsychiatric disorder (for recent updates and comprehensive reviews of previous studies of the regional neuropathology of schizophrenia as well as an extensive compilation of the pertinent more general literature on this subject, see Carpenter and Buchanan,1 Kerwin,2 Shapiro,3 and Winn4). There are a number of compelling reasons that justify intense research efforts to delineate the central nervous system (CNS) lesions that constitute a primary "cause" of schizophrenia as well as those secondary events that underlie the varied behavioral symptoms of this highly complex disease. Specifically, the identification of such lesions would markedly enhance the pace of research on schizophrenia by enabling investigators to (1) generate testable hypotheses about the cause and molecular pathogenesis of this disorder; (2) develop specific . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.